797 results on '"Walsh, Garrett L."'
Search Results
2. Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non–small cell lung cancer: Evidence for surgery in advanced disease
3. Impact of travel distance on receipt of indicated adjuvant therapy in resected non–small cell lung cancer
4. Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival
5. Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer
6. Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy
7. Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery
8. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma
9. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals
10. Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?
11. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
12. Financial Toxicity in Patients With Resected Lung Cancer
13. Repeated Pulmonary Metastasectomy: Third Operations and Beyond
14. Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers
15. Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
16. Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients
17. The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era
18. Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients
19. Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer
20. Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes
21. Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer
22. Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection
23. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed
24. Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma
25. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy
26. Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy
27. Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications
28. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for whom Surgery Should Not Be Delayed
29. Effect of primary colorectal cancer tumor location on survival after pulmonary metastasectomy
30. Postoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac
31. Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation
32. Predictors of survival following surgical resection of limited-stage small cell lung cancer
33. Ketorolac use and anastomotic leak in patients with esophageal cancer
34. LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence
35. Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively
36. Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients
37. Early Interventional Treatment of High Output Chyle Leak following Esophagectomy is Associated with Improved Survival
38. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
39. Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding
40. 18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer
41. Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non–small cell lung cancer
42. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma
43. Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience
44. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases
45. Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing
46. Octreotide's role in the management of post-esophagectomy chylothorax.
47. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women
48. Early Foley catheter removal in thoracic surgical oncology patients receiving epidural analgesia
49. Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components
50. Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.